Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
For medical device manufacturers, federal preemption can be a powerful defense to state tort claims. Although there is some split of authority, most federal courts of appeals that have addressed the issue have held that when a medical device reaches the market via the Food and Drug Administration's (FDA) rigorous “premarket approval” (PMA) process, many state common law claims are expressly preempted by the Medical Device Amendments (MDA) of 1976.
The emergence of new and innovative medical products that combine FDA-regulated devices with either a drug or biologic component, however, raises the question whether manufacturers will be able to successfully assert preemption as a defense to state tort claims arising from these “combination products.” See Laura Lewis Owens and Courtney Carter Fletcher: Combination Products: Is It a Drug, Medical Device, or Biologic? (unpublished manuscript, on file with Laura Lewis Owens, Alston & Bird, LLP). Although conventional wisdom would lead many to conclude that a preemption defense should be successful for many medical device combination products, at least one federal district court decision seems to conclude that the MDA's preemption provision never applies to “combination products.”
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
There's current litigation in the ongoing Beach Boys litigation saga. A lawsuit filed in 2019 against Nevada residents Mike Love and his wife Jacquelyne in the U.S. District Court for the District of Nevada that alleges inaccurate payment by the Loves under the retainer agreement and seeks $84.5 million in damages.
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
The real property transfer tax does not apply to all leases, and understanding the tax rules of the applicable jurisdiction can allow parties to plan ahead to avoid unnecessary tax liability.